MedTrace Logo

Oestrogen Withdrawal in Hypopituitary Women

NCT00572390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2007-12-13

No results posted yet for this study

Summary

By exploring hormonal status in hypopituitary women during oestrogen treatment and without estrogen substitution the influence on sexhormones and organ function is estimated.

Conditions

  • Hypopituitarism

Interventions

DRUG

oestrogen

Cyclic oestrogen substitution therapy

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Jens J Christiansen, PhD · Århus Universityhospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-01-31
Completion
2002-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00572390 on ClinicalTrials.gov